Top Markets
Coin of the day
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Rank in Stocks #33498
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Share Price
$1.12
Last synced: 2026-08-14
Market Cap
$7.52M
Change (1 day)
4.51%
Change (1 year)
-94.79%
Country
US
Trade NeoImmuneTech, Inc. (950220)

Category

Price of 950220 with the market cap of B
NeoImmuneTech, Inc. NeoImmuneTech, Inc.
950220
$1.12
Market Capitalization of NeoImmuneTech, Inc.(950220)
Market Cap: $7.52M
As of August 2026 NeoImmuneTech, Inc. has a market cap of $7.52M. This makes NeoImmuneTech, Inc. the world's 33498th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of NeoImmuneTech, Inc. from 2021 to 2026
950220 compared with Top 5 Most Popular stocks
Price of 950220 Asset B Mkt. of B Results
NeoImmuneTech, Inc. NeoImmuneTech, Inc.
$813,009 $7.52M
$5.452T +72,531,007.53%
NeoImmuneTech, Inc. NeoImmuneTech, Inc.
$669,574 $7.52M
$4.490T +59,734,682.95%
NeoImmuneTech, Inc. NeoImmuneTech, Inc.
$620,719 $7.52M
$4.162T +55,376,150.09%
NeoImmuneTech, Inc. NeoImmuneTech, Inc.
$548,234 $7.52M
$3.676T +48,909,595.14%
NeoImmuneTech, Inc. NeoImmuneTech, Inc.
$422,477 $7.52M
$2.833T +37,690,418.07%